Formation of 8-iso-PGF(2alpha) and thromboxane A(2) by stimulation with several activators of phospholipase A(2) in the isolated human umbilical vein.
We investigated the effects of the phospholipase A(2) (PLA(2)) activators calcium ionophore A 23187, hydrogen peroxide (H(2)O(2)), bradykinin (BK), histamine and noradrenaline (NA) on the 8-iso-prostaglandin (PG)F(2alpha) formation in the isolated human umbilical vein and the isolated rabbit ear. For comparison, the influence of these substances on the thromboxane A(2) (TXA(2)) release was also investigated. The release of total (esterified as well as free) 8-iso-PGF(2alpha), free 8-iso-PGF(2alpha) and TXB(2), the stable metabolite of TXA(2), was determined by specific enzyme immunoassays. The results show that bolus injections of 5.4 mmol H(2)O(2), 30 nmol A 23187, 10 nmol BK, 50 nmol histamine and 20 nmol NA caused an increased release of total 8-iso-PGF(2alpha) in the umbilical vein and the rabbit ear. A perfusion with H(2)O(2) at a final concentration of 0.3 mM also increased the release of this isoprostane. Increased formation of free 8-iso-PGF(2alpha) was induced by A 23187 injection and by both modes of H(2)O(2) administration, but not by the other treatments. Bolus injections of A 23187, BK and histamine induced an increased release of TXB(2) in both organs. Both modes of H(2)O(2) administration and NA showed no releasing effects. In conclusion, our results show that the substances used are able to stimulate the formation of 8-iso-PGF(2alpha) concurrently with the release of PGs. This effect might be of pathophysiological relevance in inflammatory and cardiovascular diseases in which an enhanced release of free radicals, BK, histamine or NA play an important role.
Sametz
W
W
Department of Biomedical Research, University of Graz, Roseggerweg 48, A-8036 Graz, Austria.
Hummer
K
K
Butter
M
M
Wintersteiger
R
R
Juan
H
H
D000818:Animals; D001920:Bradykinin / Q000494:pharmacology; D000001:Calcimycin / Q000494:pharmacology; D015237:Dinoprost / Q000031:analogs & derivatives* / Q000096:biosynthesis; D028441:F2-Isoprostanes; D005260:Female; D006632:Histamine / Q000494:pharmacology; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010477:Perfusion; D010741:Phospholipases A / Q000502:physiology*; D011817:Rabbits; D013928:Thromboxane A2 / Q000096:biosynthesis*; D014471:Umbilical Veins / Q000378:metabolism*
D028441:F2-Isoprostanes; C075750:8-epi-prostaglandin F2alpha; D000001:Calcimycin; D013928:Thromboxane A2; D006632:Histamine; D015237:Dinoprost; D006861:Hydrogen Peroxide; D010741:Phospholipases A; D001920:Bradykinin; D009638:Norepinephrine